Wilson Sonsini - ECP

Global Generics

Our Industry Coverage

Today’s generic pharmaceutical market is high paced and rapidly growing. With change comes increasing regulation and drive to support research and development, which Wilson Sonsini has deep expertise navigating for its clients. Through specialized support and industry knowledge, our attorneys can assemble a team to bring pharmaceutical offerings to global markets.

Industry Highlights

Celebrating our founders’ successes

2020

Mylan Set to Acquire Aspen Pharmaceutical's Thrombosis Business for $756 Million

Generics and Specialty Pharmaceuticals

2020

Pfenex Acquired by Ligand Pharmaceuticals for $566 Million

Biotechnology (Protein Therapies)

Attorneys

focused
on this
industry

See all ECP attorneys

Andrew
Hoffman

See all ECP attorneys

recent news

we want to share
with you

2023 Mid-Year Technology and Life Sciences PIPE and RDO Report

2023 Mid-Year Technology and Life Sciences PIPE and RDO Report

Newsletters09/13/23
Life Sciences COVID-19 Toolkit
See all news
See all news

other industries

we have covered